Stock Track | TG Therapeutics Soars 5.01% Intraday on High Growth Projections and Upside Potential

Stock Track01-16

TG Therapeutics Inc. (TGTX) surged 5.01% intraday on Thursday, driven by optimism over its high growth prospects and significant upside potential.

According to a MarketWatch analysis, TGTX is among 25 small-cap stocks projected to achieve a 40% compound annual growth rate (CAGR) in revenue through 2027. Analysts also see a 52% upside potential for the stock, with a consensus price target of $44.86 compared to its recent price of $29.54.

The strong growth projections and bullish price targets have attracted investor interest, fueling the stock's upward movement during the trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment